- ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia. Shankar, D.B., Li, J., Tapang, P., Owen McCall, J., Pease, L.J., Dai, Y., Wei, R.Q., Albert, D.H., Bouska, J.J., Osterling, D.J., Guo, J., Marcotte, P.A., Johnson, E.F., Soni, N., Hartandi, K., Michaelides, M.R., Davidsen, S.K., Priceman, S.J., Chang, J.C., Rhodes, K., Shah, N., Moore, T.B., Sakamoto, K.M., Glaser, K.B. Blood (2007)